ID

16034

Description

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00185042

Lien

https://clinicaltrials.gov/show/NCT00185042

Mots-clés

Versions (1)
  1. 26/06/2016 26/06/2016 -
Téléchargé le

26 juin 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Coronary Heart Disease NCT00185042

Anglais

Eligibility Coronary Heart Disease NCT00185042

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
standard:
Description

ID.1

Type de données

boolean

1. male or female subjects, age 18 years or greater; and
Description

gender and age

Type de données

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0079399
2. diagnosed or suspected coronary artery disease with a clinical indication for coronary angiography.
Description

cad and indication for coronary angiography

Type de données

boolean

Alias
UMLS CUI [1,1]
C1956346
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0085532
angiographic:
Description

ID.4

Type de données

boolean

1. evidence of coronary heart disease
Description

evidence of coronary heart disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C3887511
UMLS CUI [1,2]
C0010068
2. identification of a target native coronary artery for the plaque volume measurement.
Description

ID.6

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
standard:
Description

ID.7

Type de données

boolean

1. breast feeding or lactating women, or women who have had a pregnancy (regardless of outcome) within the past 12 months;
Description

pregnant or lactating

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
2. previous heart or other organ transplantation;
Description

previous transplantation

Type de données

boolean

Alias
UMLS CUI [1]
C0040732
3. treatment with any of the following agents within 4 weeks prior to randomization:
Description

ID.10

Type de données

boolean

immunosuppressive agents (cyclosporine, azathioprine);
Description

immunosuppressive agents

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0021081
rifampin; and
Description

prior rifampin therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0035608
phenytoin, phenobarbital, valproic acid, or other anticonvulsants.
Description

prior therapy with anticonvulsants

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0003286
4. any of the following manifestations of cardiac disease:
Description

ID.14

Type de données

boolean

myocardial infarction or unstable angina within 24 hours prior to randomization or clinically unstable;
Description

myocardial infarction or unstable angina

Type de données

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0002965
clinically significant heart disease; and
Description

clinically significant heart disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C2826293
coronary artery bypass surgery within previous 3 months.
Description

coronary artery bypass surgery

Type de données

boolean

Alias
UMLS CUI [1]
C0010055
5. stroke (cva) within previous 3 months;
Description

stroke

Type de données

boolean

Alias
UMLS CUI [1]
C0038454
6. evidence of severe symptomatic heart failure (nyha class iii or iv) or known ejection fraction less than 30%;
Description

severe symptomatic heart failure

Type de données

boolean

Alias
UMLS CUI [1]
C0742758
7. uncontrolled diabetes mellitus;
Description

uncontrolled diabetes mellitus

Type de données

boolean

Alias
UMLS CUI [1]
C0421258
8. uncontrolled hypertension; and
Description

uncontrolled hypertension

Type de données

boolean

Alias
UMLS CUI [1]
C1868885
9. nephrotic syndrome, significant nephropathy, or other significant renal disease.
Description

kidney disease

Type de données

boolean

Alias
UMLS CUI [1]
C0022658
angiographic:
Description

ID.23

Type de données

boolean

1. presence of any lesion with greater than 50% reduction in lumen diameter; or
Description

sclerotic lesion

Type de données

boolean

Alias
UMLS CUI [1]
C0748541
2. any lesion with a greater than 50% occlusion in the left main coronary artery;
Description

occlusion in the left main coronary artery

Type de données

boolean

Alias
UMLS CUI [1,1]
C0748541
UMLS CUI [1,2]
C0226031
3. a target vessel, including any of its branches, that has undergone or will be undergoing coronary artery bypass grafting (cabg) or percutaneous coronary intervention (pci);
Description

pci or cabg on target vessel

Type de données

boolean

Alias
UMLS CUI [1,1]
C0449618
UMLS CUI [1,2]
C0010055
UMLS CUI [2,1]
C0449618
UMLS CUI [2,2]
C1532338
4. a target vessel that is itself a bypass graft.
Description

target vessel bypass graft

Type de données

boolean

Alias
UMLS CUI [1,1]
C0449618
UMLS CUI [1,2]
C0185098
Retour au début de la page

Similar models

Eligibility Coronary Heart Disease NCT00185042

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
standard:
boolean
gender and age
Item
1. male or female subjects, age 18 years or greater; and
boolean
C0001779 (UMLS CUI [1,1])
C0079399 (UMLS CUI [1,2])
cad and indication for coronary angiography
Item
2. diagnosed or suspected coronary artery disease with a clinical indication for coronary angiography.
boolean
C1956346 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0085532 (UMLS CUI [1,3])
ID.4
Item
angiographic:
boolean
evidence of coronary heart disease
Item
1. evidence of coronary heart disease
boolean
C3887511 (UMLS CUI [1,1])
C0010068 (UMLS CUI [1,2])
ID.6
Item
2. identification of a target native coronary artery for the plaque volume measurement.
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
standard:
boolean
pregnant or lactating
Item
1. breast feeding or lactating women, or women who have had a pregnancy (regardless of outcome) within the past 12 months;
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
previous transplantation
Item
2. previous heart or other organ transplantation;
boolean
C0040732 (UMLS CUI [1])
ID.10
Item
3. treatment with any of the following agents within 4 weeks prior to randomization:
boolean
immunosuppressive agents
Item
immunosuppressive agents (cyclosporine, azathioprine);
boolean
C1514463 (UMLS CUI [1,1])
C0021081 (UMLS CUI [1,2])
prior rifampin therapy
Item
rifampin; and
boolean
C1514463 (UMLS CUI [1,1])
C0035608 (UMLS CUI [1,2])
prior therapy with anticonvulsants
Item
phenytoin, phenobarbital, valproic acid, or other anticonvulsants.
boolean
C1514463 (UMLS CUI [1,1])
C0003286 (UMLS CUI [1,2])
ID.14
Item
4. any of the following manifestations of cardiac disease:
boolean
myocardial infarction or unstable angina
Item
myocardial infarction or unstable angina within 24 hours prior to randomization or clinically unstable;
boolean
C0027051 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
clinically significant heart disease
Item
clinically significant heart disease; and
boolean
C0018799 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
coronary artery bypass surgery
Item
coronary artery bypass surgery within previous 3 months.
boolean
C0010055 (UMLS CUI [1])
stroke
Item
5. stroke (cva) within previous 3 months;
boolean
C0038454 (UMLS CUI [1])
severe symptomatic heart failure
Item
6. evidence of severe symptomatic heart failure (nyha class iii or iv) or known ejection fraction less than 30%;
boolean
C0742758 (UMLS CUI [1])
uncontrolled diabetes mellitus
Item
7. uncontrolled diabetes mellitus;
boolean
C0421258 (UMLS CUI [1])
uncontrolled hypertension
Item
8. uncontrolled hypertension; and
boolean
C1868885 (UMLS CUI [1])
kidney disease
Item
9. nephrotic syndrome, significant nephropathy, or other significant renal disease.
boolean
C0022658 (UMLS CUI [1])
ID.23
Item
angiographic:
boolean
sclerotic lesion
Item
1. presence of any lesion with greater than 50% reduction in lumen diameter; or
boolean
C0748541 (UMLS CUI [1])
occlusion in the left main coronary artery
Item
2. any lesion with a greater than 50% occlusion in the left main coronary artery;
boolean
C0748541 (UMLS CUI [1,1])
C0226031 (UMLS CUI [1,2])
pci or cabg on target vessel
Item
3. a target vessel, including any of its branches, that has undergone or will be undergoing coronary artery bypass grafting (cabg) or percutaneous coronary intervention (pci);
boolean
C0449618 (UMLS CUI [1,1])
C0010055 (UMLS CUI [1,2])
C0449618 (UMLS CUI [2,1])
C1532338 (UMLS CUI [2,2])
target vessel bypass graft
Item
4. a target vessel that is itself a bypass graft.
boolean
C0449618 (UMLS CUI [1,1])
C0185098 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial